Loestrin 24 Fe

Quick links to important sections

Loestrin 24 Fe

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Loestrin 24 Fe

Quick Facts

Property Description
Active ingredient Ethinyl Estradiol, Norethisterone Acetate
Form Oral Tablet
Pharmacological Class Synthetic Steroid Hormone Preparation
Common Use Contraception (Pregnancy Prevention)
Origin Synthetic

Loestrin 24 Fe: Classification and Identity

Loestrin 24 Fe is a Combined Oral Contraceptive (COC), a medicine requiring a prescription, administered orally in tablet form. Its core identity is based on the use of two synthetic hormone types: the estrogen, Ethinyl Estradiol, and the progestin, Norethisterone Acetate. This preparation is chemically engineered and belongs to the broader class of Synthetic Steroid Hormone Preparations. Its utility in preventing pregnancy is recognized based on pharmacological data, establishing its place as a clinically recognized method of birth control.

Composition and Drug Form: Estrogen, Progestin, and the "Fe" Component

The specific formulation of Loestrin 24 Fe is defined by two key factors. First, it utilizes a monophasic structure, delivering a constant level of active hormones during the twenty-four active days of the regimen. Second, it is distinguished by the inclusion of non-hormonal tablets containing Ferrous Fumarate (Iron) in the 28-day regimen. The presence of these iron supplement tablets, referenced by the "Fe," serves the primary function of assisting users in maintaining a continuous daily routine, thus promoting adherence. Other similar formulations containing the same active ingredients include Blisovi 24 Fe and Junel Fe 24.

General Purpose: Why is Loestrin 24 Fe Used?

The dedicated and sole general purpose of Loestrin 24 Fe is pregnancy prevention and contraception for women of reproductive potential. The combined hormonal approach establishes a multi-layered mechanism to manage the reproductive cycle. This hormonal modulation provides patients with a reliable, predictable, and established method for proactively controlling their fertility status, consistent with the efficacy of estrogen-progestin combinations in family planning.

What side effects are possible with Loestrin 24 Fe?

Possible side effects and safety information

The official regulatory safety profile of Loestrin 24 Fe, a combined oral contraceptive, is defined by documented common non-serious adverse reactions and a formal acknowledgment of rare, serious systemic risks.

Adverse effects are classified by the physiological system affected (System-Organ-Classes) and by their observed frequency. Common adverse reactions include nausea, headache, breast tenderness or pain, and irregular uterine bleeding or spotting, especially during the initial treatment cycles. Effects are formally listed across Gastrointestinal, Nervous System, Reproductive System and Breast, and Metabolism and Nutrition disorders.


Serious Adverse Reactions and Safety Constraints

The use of combined hormonal contraceptives is associated with an increased risk of serious adverse reactions. These clinically significant risks include Thrombotic and Thromboembolic Events (such as Deep Vein Thrombosis, Pulmonary Embolism, Stroke, and Myocardial Infarction) and Hepatic Neoplasia (liver tumors).

Risk patterns are often tied to specific factors or duration. The risk of VTE is noted as being highest during the first year of use and when treatment is re-initiated after a break. Safety constraints define several absolute contraindications where the medication must not be used, including a history of VTE or arterial thrombotic disease, known or suspected breast cancer, liver disease, or uncontrolled hypertension.


Population-Specific Safety Note: The regulatory label specifies a significantly increased risk of serious cardiovascular events, making the medication contraindicated for women over 35 years old who smoke.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Loestrin 24 Fe addresses two distinct risks: the hormonal tablets and the iron-containing tablets.

Overdose of the active hormonal components (Norethisterone Acetate and Ethinyl Estradiol) is typically not life-threatening. The officially documented manifestations include nausea, vomiting, and withdrawal bleeding (vaginal bleeding).

However, a severe and explicit regulatory warning exists concerning the ferrous fumarate (iron) tablets. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. This documented risk necessitates specific emergency actions.

Overdose Component Associated Risk & Action
Hormonal Tablets Typically non-life-threatening. No specific antidote is known; management is symptomatic and supportive.
Iron Tablets (Fe) High risk of fatal poisoning in children under 6. Requires immediate emergency medical attention.

In any suspected overdose, government guidelines mandate that you seek emergency medical attention immediately and contact a Poison Control Center for guidance. Treatment is focused on supportive care, which may include monitoring of vital signs.

Therapeutic Uses of Loestrin 24 Fe

What Loestrin 24 Fe Treats: Main Uses and Benefits

Loestrin 24 Fe is a hormonal therapy used to prevent pregnancy for women of reproductive potential. This core application may assist with maintaining functional stability by supporting patients with the management of their fertility status.

The medication is commonly used in clinical settings that involve heightened systemic burden, relevant for easing symptoms related to systemic imbalance. Key indications may include managing severe acne, supporting the patient with painful periods (dysmenorrhea), and helping to manage heavy menstrual flow and irregular cycles. This approach is generally applied in contexts where additional symptomatic support is needed.

Furthermore, its consistent use is associated with a reduced risk of developing ovarian cysts and certain gynecological cancers. This provides a supportive benefit: “The use of this medication supports the establishment of a regular menstrual pattern, which contributes to easing overall symptom burden.”


Quick Fact: Therapeutic Context Therapeutic Benefit Provided
Fertility Control Assists with the management of reproductive status.
Menstrual Discomfort May contribute to the ease of symptoms related to cramping and heavy bleeding.
Acne Used in the management of severe acne symptoms.

Eligibility and Restrictions for Use

Official Eligibility Profile for Loestrin 24 Fe

Eligibility to use Loestrin 24 Fe, a combined oral contraceptive (COC), is strictly defined by regulatory guidelines to minimize the risk of serious side effects, primarily cardiovascular events and certain cancers. The medicine is indicated for use by women of reproductive age for the prevention of pregnancy.


Contraindicated Populations (Must Not Use)

Criteria
Women over 35 years old who smoke
Women with a current or history of breast cancer or other hormone-sensitive cancer
Women with a current or history of deep vein thrombosis (DVT), pulmonary embolism (PE), or other thrombotic conditions
Women with migraine headaches with aura
Women with severe liver disease or liver tumors
Women with undiagnosed abnormal uterine bleeding
Women currently pregnant
Women taking certain Hepatitis C combination drugs

Eligibility Restrictions

  • Postpartum Use: Use is generally not recommended immediately after delivery; non-breastfeeding women should wait at least four weeks due to the increased risk of blood clots during this period.
  • Breastfeeding: The use of COCs is not recommended as the hormones may reduce the quantity and quality of breast milk.
  • Age Limits: Use is not established in women over 65 or in patients prior to menarche.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

This section outlines documented interactions between Loestrin 24 Fe and other substances, based on official regulatory information. This information is descriptive and does not constitute medical advice.


Key Interaction Categories

Interaction Type Examples and Effects Constraint Level
Contraindicated Combinations Hepatitis C drug regimens containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir. Absolute Prohibition
Enzyme Inducers Medicines like rifampin, phenytoin, and St. John's Wort. Reduced effectiveness (lower hormone levels)
Enzyme Inhibitors Certain antifungals (itraconazole, ketoconazole) and Grapefruit Juice. Increased exposure (higher hormone levels)

Additional Noted Interactions

Metabolism Interference: The product may inhibit the metabolism of other co-administered therapeutic agents, such as cyclosporine or theophylline, leading to increased plasma concentrations of these medicines.

Non-Hormonal Component Constraint: The iron component (ferrous fumarate) can interfere with the absorption of certain oral medications, including specific antibiotics (e.g., ciprofloxacin, tetracycline). Doses of the iron tablets and these specific medicines must be separated by at least 2 hours.

Other Modifiers: Common substances like Ascorbic Acid (Vitamin C) and acetaminophen are documented to increase the exposure of the hormonal components.

Mechanism of Action

Modulation of the Hypothalamic-Pituitary-Ovarian Axis

This core mechanistic domain involves the drug's active components, an estrogen and a progestin, acting within domains of steroid hormone receptor-mediated signaling. By binding to target receptors, the drug suppresses the cyclical release of GnRH, which consequentially inhibits the secretion of LH and FSH from the pituitary gland. This results in the modulation of cyclical hormonal fluctuations and the absence of the LH surge required for follicular rupture.

Altering Local Reproductive Tissue Environments

The drug engages mechanisms that regulate biological processes within the cervix and the endometrium, modifying early molecular steps that shape local physiological outcomes. This mechanism results in the thickening of the cervical mucus (inducing alterations in cervical mucus viscosity), and causing changes in endometrial morphology and receptivity.

Dosage and Administration Information

How to Use Loestrin 24 Fe

Loestrin 24 Fe is administered as an oral tablet and follows a strict 28-day cyclic dosing regimen. The fundamental instruction is to take one tablet daily, at the same time every day, without interruption.


Administration Protocol

Instruction Category Official Guideline
Route of Administration Oral (swallowed by mouth).
Dosing Schedule One tablet daily for 28 consecutive days. This comprises 24 active white tablets (1 mg Norethindrone Acetate / 20 mcg Ethinyl Estradiol) followed by 4 inactive brown tablets (Ferrous Fumarate).
Intake Condition May be taken with or without food.
Dosing Order Tablets must be taken in the sequential order directed on the blister pack.

Starting the Medication and Continuous Use

Therapy must be initiated using one of two methods: the Day 1 Start or the Sunday Start method. For the Sunday Start, the use of additional non-hormonal contraception is recommended for the first 7 days.

For continuous use, upon completion of the 28th tablet, a new pack must be started the very next day. This ensures the continuous, indefinite pattern of 24 active days followed by 4 inactive days, maintaining the structured regimen. Tablets should not be skipped or taken at intervals exceeding 24 hours.

Recent Clinical Evidence

Overview of Clinical Trials

Loestrin 24 Fe is a combination oral contraceptive regimen consisting of 24 active hormone tablets and 4 non-hormonal ferrous fumarate tablets. The active tablets contain norethindrone acetate (a progestin) and ethinyl estradiol (an estrogen).

Clinical trials were conducted to assess the effectiveness of the 24-day active regimen in preventing pregnancy. The primary mechanism studied involves the suppression of ovulation, supplemented by alterations to cervical mucus and the uterine lining. The studies focused on women between the ages of 18 and 45 who were at risk for pregnancy.


Efficacy and Bleeding Profile

Research has shown that the regimen meets established standards for contraceptive effectiveness. In one 6-month, randomized, active-controlled study comparing the 24-day regimen to a traditional 21-day regimen, the 24-day approach was associated with a lower number of intracyclic bleeding days and fewer days of withdrawal bleeding. This difference in bleeding patterns is attributed to the extended duration of active hormone administration.


Tolerability and Safety Findings

In clinical evaluations, the most commonly reported side effects were generally mild to moderate in severity, including headache, nausea, and changes in bleeding patterns. The safety profile observed in trials was comparable to that of other low-dose combination oral contraceptives. Studies did not evaluate the efficacy of the medication in women with a body mass index (BMI) greater than 35 kg/m^2.

Frequently Asked Questions (FAQ)

Common questions about Loestrin 24 Fe (FAQ)


Q: Is Loestrin 24 Fe considered a 'low-dose' birth control pill?

Yes, compared to many older contraceptive formulations, Loestrin 24 Fe is considered a low-dose pill. This classification is primarily based on the amount of the estrogen component, ethinyl estradiol, which is 20 micrograms in the active tablets.


Q: Why does the packaging for Loestrin 24 Fe include iron (ferrous fumarate)?

The four brown pills at the end of the 28-day pack contain ferrous fumarate, which is a non-hormonal iron supplement. According to official product information, these inactive pills are included to help the user maintain a consistent, continuous daily routine of taking a tablet, which is described as promoting adherence to the regimen.


Q: Can taking Loestrin 24 Fe increase the risk of developing certain cancers?

Official information notes that the use of combined oral contraceptives is associated with an increased risk of certain liver tumors. Furthermore, the medicine is contraindicated (must not be used) in women with a known or suspected history of breast cancer or other hormone-sensitive cancers, as defined by regulatory documents.


Q: Can grapefruit juice or large amounts of caffeine interact with Loestrin 24 Fe?

Regulatory information documents that grapefruit juice can interact with the hormones, which may increase the amount of the hormones in the body. Since the estrogen component affects certain metabolic pathways, it may also influence the concentration of substances metabolized by similar pathways, such as caffeine.


Q: Does taking the pill affect future fertility after stopping it?

Official information notes that some women have reported experiencing amenorrhea (not having a period) or oligomenorrhea (infrequent periods) after stopping combined oral contraceptives. This is noted to be especially true if they experienced these conditions before they began taking the medication.


Q: What is the difference between Loestrin 24 Fe and other 'Fe' pills like Minastrin 24 Fe?

Loestrin 24 Fe is one of several brands, including generics, that contain the same active ingredients and dosage strength—norethindrone acetate and ethinyl estradiol. These products utilize the same 24/4 regimen structure.


Q: Is the ferrous fumarate meant to be absorbed or is it considered a placebo?

The ferrous fumarate tablets are non-hormonal, meaning they are inactive for the purpose of contraception. They are included primarily to help maintain the pill-taking schedule and, secondarily, they are composed of ferrous fumarate (iron).


Q: Can Loestrin 24 Fe be used to manage symptoms of endometriosis or PCOS?

The sole indicated use (approved purpose) for Loestrin 24 Fe, as defined in the official prescribing information, is for the prevention of pregnancy. It is not officially indicated for the management of endometriosis or Polycystic Ovary Syndrome (PCOS).


Q: Is Loestrin 24 Fe a monophasic or multiphasic oral contraceptive?

Loestrin 24 Fe is classified as a monophasic oral contraceptive. This means that each of the 24 active hormone pills in the blister pack contains the same, constant amount of both the estrogen and progestin hormones.


Q: What should be done if spotting or bleeding occurs between periods while taking this medication?

Irregular bleeding or spotting between periods is a commonly reported side effect of this medication, particularly during the first few months of use. Official materials note that continued use may lead to the resolution of this bleeding.


Q: What is the typical time frame for side effects like spotting to resolve after starting the pill?

Irregular bleeding (spotting) is most common during the first few months. The official patient information notes that this side effect will usually go away as the body adjusts to the medication, and documents indicate that continued use is associated with its resolution.


Q: Can Loestrin 24 Fe cause changes in body weight or appetite?

Official regulatory documents list changes in weight as a common adverse reaction observed in clinical studies of the medication. This observation is included in the official safety information provided by the manufacturer.


Q: Are mood changes, like anxiety or depression, listed as possible side effects?

Yes, mood changes, including anxiety and depression, are reported as common adverse reactions in clinical studies. Official information also indicates that women with a history of depression may require careful observation while on the medication.


Q: Does Loestrin 24 Fe cause acne or is it used to manage acne?

According to official regulatory documents, acne is reported as a common adverse reaction in the clinical studies of the medication.


Q: Is it possible to experience a change in sex drive while taking Loestrin 24 Fe?

Official information for combined oral contraceptives notes that a decrease in sex drive, or libido, is included in the overall listing of less common adverse reactions reported by users.


Q: Are there specific symptoms that require immediate medical attention while using this drug?

Yes, the official patient information highlights several symptoms related to serious events associated with the medication. These include symptoms related to serious events, such as those indicating a blood clot, stroke, heart attack, or liver problems, as detailed in the official patient information.


Q: Is there an increased risk of side effects when taking Loestrin 24 Fe and certain herbal supplements?

The official drug interaction information specifically lists the herbal supplement St. John's wort as an enzyme inducer. This type of substance can reduce the effectiveness of the contraceptive and may increase the risk of certain side effects.


Q: Can vomiting or diarrhea affect the effectiveness of Loestrin 24 Fe?

If severe vomiting or diarrhea occurs within 3 to 4 hours after taking an active tablet, the absorption of the hormones may be incomplete. Regulatory instructions handle this situation in the same way they address a missed pill.


Q: Are there any reported long-term side effects after stopping Loestrin 24 Fe?

Official information notes that some women have reported experiencing amenorrhea (not having a period) or oligomenorrhea (infrequent periods) after stopping combined oral contraceptives. This is reported especially if these conditions were present before they started the medication.


Q: What are the typical benefits of using a combination oral contraceptive like this one, besides pregnancy prevention?

In addition to its sole approved purpose of pregnancy prevention, combination oral contraceptives are sometimes noted to result in lighter and shorter menstrual bleeding compared to periods experienced when not on the pill.


Q: Does Loestrin 24 Fe have any effect on bone mineral density?

Studies examining combination oral contraceptives generally show that changes in bone mineral density among users were not significantly different when compared to women using non-hormonal contraception or no contraception.


Q: Is it possible for the medication to affect cholesterol or triglyceride levels?

Official prescribing information states that combined oral contraceptives can affect carbohydrate and lipid metabolism. Regulatory materials note that for women with uncontrolled dyslipidemia (abnormal cholesterol or triglyceride levels), an alternative contraceptive method may be indicated.


Q: Are there any known effects of Loestrin 24 Fe on gallbladder health?

The official product label notes that studies indicate an increased risk of gallbladder disease in users of combined oral contraceptives. Symptoms of potential gallbladder problems are listed in regulatory documents for awareness.


Q: Why do some active pills have different colors in the blister pack?

The official packaging description indicates that the 24 active hormone pills are typically a single color, reflecting that they all contain the same dose of hormones. The last four non-hormonal iron tablets are a different color to distinguish them from the active pills.

How should Loestrin 24 Fe be stored and disposed of?

How to Store and Dispose of Loestrin 24 Fe

The official regulatory instructions for storing and handling Loestrin 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) require adherence to specific environmental conditions to maintain the drug's quality and stability.

Official Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature.
Light Protection Protect from light.
Packaging Must be dispensed and stored in the original blister card.

Handling and Disposal

The product must be maintained in its original dispensing blister card to protect it from light. Official regulatory labeling does not typically include product-specific disposal instructions in the storage section. Patients should follow general, officially approved drug disposal procedures for unused or expired medication, ensuring proper environmental handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Loestrin 24 Fe found in:

A-Z Index: